Published: Sat, January 30, 2021
Medical | By

France’s Sanofi to make Covid vaccines from rival Pfizer/BioNTech

France’s Sanofi to make Covid vaccines from rival Pfizer/BioNTech

The discovery was initially heralded as a way to stretch the precious vaccine even further.

Saskatchewan didn't receive any shipments of the Pfizer vaccine this week, but was still administering shots by getting six doses out of many vials.

The Pfizer and Moderna vaccines are now being given to health care workers, nursing home residents and older Americans.

Canada is also due to receive two million doses of Moderna's COVID-19 vaccine by March 31 and said the entire country should have been inoculated at some point in September.

It is unknown if all Pfizer-BioNTech vaccine supplies for Malaysia will be delivered to Singapore for distribution here, instead of shipments flown directly from Europe to Malaysia. While a phase 1/2 study has yet to begin, preclinical data determined that two doses of the vaccine provided high neutralizing antibody levels comparable to the upper range found in the naturally infected.

Dr. Howard Njoo, Canada's deputy chief public health officer, noted that it is "standard" for a bit of extra fluid to remain in a vial following a vaccination. "First and foremost, we will do this by continuing to develop our own COVID-19 vaccines candidates, in parallel with this industrial cooperation".


During a press briefing on Thursday, Maj. "In other jurisdictions, we did not have the right equipment, just could not do this consistently".

AstraZeneca was the first to apply for approval for a COVID-19 vaccine in Canada and has been greenlit in 15 jurisdictions including the United Kingdom, Mexico, India, and as of Friday, the entire European Union.

Pfizer is also now asking Canada to agree each of its vials contains six doses, rather than five, which would allow it to ultimately ship fewer vials to meet its obligation of four million doses by the end of March, and 40 million by the fall.

During the test run, the temperature in the thermal shipper could be maintained between -90 to - 60 degrees Celsius and this ensured that the Pfizer vaccine is in flawless condition when it reaches its destination.

Global pharmaceutical company Novartis announced Friday it signed an early agreement to boost manufacturing capacity for the Pfizer-BioNTech coronavirus vaccine.

Syringe and vial of Pfizer-BioNTech vaccine in Halifax.

Like this: